Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FX33C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,772
Award facts
- Contract value 100% obligated
- $3,772.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,772.16 and firm fixed pricing. This delivery order is non-set-aside and represents a competitive award for pharmaceutical procurement. The contract is scheduled for ultimate completion by August 20, 2025, with performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contract awards demonstrate versatility in fulfilling military and veteran healthcare supply needs across multiple therapeutic domains, ranging from diabetes medications to specialty pharmaceuticals and medical devices. Through its prime IDV with DLA Troop Support, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning itself as a key provider for the military's pharmaceutical logistics operations.
Quick answers
Who was awarded contract SPE2DB25FX33C?
SPE2DB25FX33C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FX33C worth?
The government has obligated $3,772 on SPE2DB25FX33C.
Is contract SPE2DB25FX33C an order under another contract?
Yes. SPE2DB25FX33C is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX33C competed?
The extent of competition for SPE2DB25FX33C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award